Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › C10RF32 antibodies, and uses thereof for treatment of cancer

C10RF32 antibodies, and uses thereof for treatment of cancer

US Patent 9617336 · Granted Apr 11, 2017

Estimated economic value: $1,733,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modulators2025
Efflux pump-cancer antigen multi-specific antibodies and compositions, reagents,2025
Anti-PVRIG antibodies and methods of use2025
Anti-CD38 binding domains2025
Anti-CD38 antibodies2025
Compositions and methods for conjugating activatable antibodies2024
PVRIG polypeptides and methods of treatment2023
Anti-PVRIG antibodies and methods of use2023
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use the2023
Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof2023
Anti-PVRIG antibodies and methods of use2023
Anti-CD38 antibodies2022